Grocery chains and packaged food makers are shrinking portion sizes and rethinking shelf space as GLP-1 users eat less and buy less. If you're on one of these medications, that shift will eventually show up in what you find at the store and how it's priced. The same week also brought a pointed question about who gets to sell these drugs, and a public defense from someone living the experience firsthand.
That reshaping is already visible in how retailers stock shelves and how manufacturers size their products. Businesses that once counted on shoppers buying multipack snacks or family-size boxes are watching those same shoppers pick up single servings instead, or skip the aisle altogether. Some companies are also noticing customers buying smaller clothing sizes, another sign that appetite suppression from these drugs is changing everyday purchasing habits, not just what ends up in the pantry. For food companies, adjusting to this shift is proving difficult, since it touches packaging, pricing and store layout all at once. If you use a GLP-1 medication, you may already have noticed you need less at the store than you used to, and it looks like the industry is finally catching up to that reality.
That same commercial interest in GLP-1 drugs is also drawing sharper questions about who profits from promoting them. Martha Stewart has come under criticism for advertising a GLP-1 medication despite saying publicly that she does not take it herself. Critics have asked directly, as one commenter put it, "How the hell can you be a spokesperson for a GLP-1 when you don't even take it??" The criticism raises a broader ethical question about celebrity endorsements in this market, and whether audiences deserve to know when a spokesperson's own experience does not match the product they are selling.
Chrissy Metz has taken the opposite approach, speaking openly about her own GLP-1 weight loss experience rather than staying silent about it. She has faced criticism for her choice, but has defended her decision publicly, treating it as her own experience to explain on her own terms. Where Stewart is questioned for promoting something she reportedly doesn't use, Metz is being questioned for using something at all, which shows how differently the public reacts depending on whether a celebrity is closer to or further from these drugs. Either way, both stories point to how much scrutiny public figures now face around GLP-1 use, whether they take the medication or simply sell it.
None of this changes how these drugs work for the person taking them, but it does show how far their effects reach into everyday life, from grocery aisles to celebrity endorsements. If you're shopping while on a GLP-1 medication, it may be worth checking whether stores near you have started stocking smaller portions or single-serve options, since that shift appears to be underway. And if you follow public figures who talk about these drugs, it's reasonable to ask what their actual experience is, whether they're selling a product or simply sharing their own story. Paying attention to that distinction can help you separate marketing from lived experience.
Key details
Grocery and packaged food companies are adjusting portion sizes as GLP-1 users buy and…
Martha Stewart's promotion of a GLP-1 drug she says she doesn't take has raised ethics…
Chrissy Metz has spoken publicly about her GLP-1 weight loss experience while facing…
Originally published on GLP-1 Nation.
Every Sunday, the weekly newsletter pulls the full week together: the news from GLP-1 Nation, the access updates from GLP1Laws, the latest GLP-1 Studio podcast episodes, and what changed in the Cozy Butter community.